A CAR against CAR for unintended consequences

Sattva S. Neelapu

doi:10.1182/blood.2019004172

A CAR against CAR for unintended consequences

Sattva S. Neelapu

Lymphoma-Myeloma

Research output: Contribution to journal › Review article › peer-review

Abstract

In this issue of Blood, Ruella and colleagues report the development of a chimeric antigen receptor (CAR) that could target anti-CD19 CAR T cells (CAR19¹ T) used for therapy of B-cell malignancies as well as leukemic B cells inadvertently transduced with anti-CD19 CAR (CAR19¹ B).¹

Original language	English (US)
Pages (from-to)	460-462
Number of pages	3
Journal	Blood
Volume	135
Issue number	7
DOIs	https://doi.org/10.1182/blood.2019004172
State	Published - Feb 13 2020

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2019004172

Cite this

@article{94d93f1933ed41c588c803202db74328,

title = "A CAR against CAR for unintended consequences",

abstract = "In this issue of Blood, Ruella and colleagues report the development of a chimeric antigen receptor (CAR) that could target anti-CD19 CAR T cells (CAR191 T) used for therapy of B-cell malignancies as well as leukemic B cells inadvertently transduced with anti-CD19 CAR (CAR191 B).1",

author = "Neelapu, {Sattva S.}",

year = "2020",

month = feb,

day = "13",

doi = "10.1182/blood.2019004172",

language = "English (US)",

volume = "135",

pages = "460--462",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "7",

}

TY - JOUR

T1 - A CAR against CAR for unintended consequences

AU - Neelapu, Sattva S.

PY - 2020/2/13

Y1 - 2020/2/13

N2 - In this issue of Blood, Ruella and colleagues report the development of a chimeric antigen receptor (CAR) that could target anti-CD19 CAR T cells (CAR191 T) used for therapy of B-cell malignancies as well as leukemic B cells inadvertently transduced with anti-CD19 CAR (CAR191 B).1

AB - In this issue of Blood, Ruella and colleagues report the development of a chimeric antigen receptor (CAR) that could target anti-CD19 CAR T cells (CAR191 T) used for therapy of B-cell malignancies as well as leukemic B cells inadvertently transduced with anti-CD19 CAR (CAR191 B).1

UR - http://www.scopus.com/inward/record.url?scp=85079673700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079673700&partnerID=8YFLogxK

U2 - 10.1182/blood.2019004172

DO - 10.1182/blood.2019004172

M3 - Review article

C2 - 32197269

AN - SCOPUS:85079673700

SN - 0006-4971

VL - 135

SP - 460

EP - 462

JO - Blood

JF - Blood

IS - 7

ER -

A CAR against CAR for unintended consequences

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this